Articles from ValGenesis

ValGenesis, the global leader in digital validation and lifecycle management solutions for the life sciences industry, today announced the appointment of David Horn as president, effective Oct. 5, 2026.

ValGenesis, a market leader in digital validation and process lifecycle solutions, announced that Avance Clinical, a leading global contract research organization (CRO) headquartered in Australia, has adopted its platform to digitally transform computer system validation (CSV) processes in alignment with Pharma 4.0 principles. The initiative will enhance efficiency, compliance, and transparency across the company’s global clinical trial operations while leveraging Australia's expedited ethics approvals and R&D incentives.